Therefore, we hypothesize that, during myositis pathogenesis in patients with anti-Jo1 antibodies, MMP9 is released from neutrophils and PBMCs, cleaving type IV collagen in the basement membranes and allowing CD8+ T lymphocyte migration and invasion of the MHC class-I-expressing muscle fibers. Here, CD8A is linked to myositis disease.